by Shubha Ghosh, PhD, JD, Crandall Melvin Professor of Law and Director, IP and Tech Commercialization Curricular Program & SIPLI
Harven DeShield, JD, PhD, and general counsel for Vivacell, a Chicago biotech start-up, visited us October, 2018, to talk about his academic and legal work that led to the technology underlying the company, which recently received FDA approval for Phase IIA Clinical Trials.